Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

NCT06696820 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

429

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: PCSK9 inhibitors combined with atorvastatin/rosuvastatin
DRUG: Atorvastatin/Rosuvastatin

Sponsor

Xiang Luo

Collaborators